Mastectomy Reconstruction Implants Market

Mastectomy Reconstruction Implants Market Snapshot (2023 to 2033)

According to Future Market Insights (FMI) analysis in a recent market survey, the global mastectomy reconstruction implants market was valued at USD 1.95 Billion in 2022 and is set to reach USD 4.69 Billion by 2033.

Market Outlook:

Data Points	Market Insights
Market Value 2022	USD 1.95 Billion
Market Value 2023	USD 2.09 Billion
Market Value 2033	USD 4.69 Billion
CAGR 2023 to 2033	8.4%
Share of Top 5 Countries	60.5%
Key Players	Mentor Worldwide LLC (Johnson & Johnson Services; Inc.); AbbVie Inc. (Allergan PLC); Hans Biomed Co.; Ltd; Galderma SA; GC Aesthetics; POLYTECH Health & Aesthetics GmbH; Sientra Inc; PMT Corporation; Ideal Implant Inc; Groupe Sebbin SAS; Hologic; Inc; Guangzhou Wanhe Plastic Materials Co.; Ltd; Establishment Labs S.A; RTI Surgical Holdings Inc; and Nagor Limited

Mastectomy reconstruction implants are breast implants that are used to reconstruct the breast tissue after a mastectomy, which is a surgical procedure in which one or both breasts are removed due to cancer or other medical conditions. The implants are typically made of silicone or saline and are placed under the chest muscle or breast tissue to create a natural-looking breast shape.

Overall, the increasing incidence of breast cancer, the growing demand for cosmetic surgeries, and the availability of technologically advanced breast implants, will boost the market in the coming years.

For instance, In 12 November 2019, BellaSeno and Evonik collaborated to bring an advanced 3D-printed breast implant technology to market. This technology designed to improve quality of life for patients after breast reconstruction and augmentation.

Sales Analysis of Mastectomy Reconstruction Implants Market from 2016 to 2022 Vs Market Outlook for 2023 to 2033

Sales of the mastectomy reconstruction implants market grew at a CAGR of 6.6% between 2016 and 2022. Mastectomy reconstruction implants market contributes 49.0% revenue share to the global breast reconstruction surgery and treatment market which is valued around USD 3.97 Billion in 2022.

There is a growing demand for breast reconstruction surgeries, and as a result, the demand for mastectomy reconstruction implants is also increasing. This is due to several factors, including rising awareness, improved surgical techniques, and the increasing incidence of breast cancer.

• According to a 2020, survey by the American Society of Plastic Surgeons, 70% of women who had breast cancer surgery knew about breast reconstruction options before their surgery, up from 61% in 2014. This shows that awareness of breast reconstruction options is growing among breast cancer survivors.

Many healthcare organizations are promoting breast reconstruction surgery and treatment as part of breast cancer care.

• For example, the American Cancer Society recommended that women learn about breast reconstruction options before undergoing a mastectomy. This has helped increase awareness of breast reconstruction options among breast cancer survivors.

There are several manufacturers in the mastectomy reconstruction implants market, and competition is high. As a result, manufacturers are focusing on developing innovative products, improving their distribution networks, and providing excellent customer service to maintain or gain market share. Manufacturers are collaborating with healthcare professionals, research institutions, and other industry players to develop new products and improve existing ones. These collaborations can help manufacturers to stay at the forefront of the market and meet the changing needs of customers.

Considering this, FMI expects the global mastectomy reconstruction implants market to grow at a CAGR of 8.4% through the forecasted years.

What are the Key Opportunities in the Mastectomy Reconstruction Implants Market?

Small-sized breast implants are becoming popular among women who desire natural-looking results from their breast reconstruction surgery. These implants can provide a subtle enhancement of breast size and shape without appearing overly artificial. This is driven by the growing awareness of the importance of natural-looking results in the market.

There has been a significant increase in the availability of small-sized breast implants in recent years. This is due to the development of new technologies and materials, as well as advances in surgical techniques. Small-sized breast implants are often used in minimally invasive breast reconstruction procedures, which are becoming increasingly popular.

The trend toward personalized medicine is also reflected in breast reconstruction surgeries. Surgeons are now better able to tailor the procedure to the individual needs of each patient, taking into account factors such as their body shape, breast size, and desired outcome. In many countries, insurance coverage for breast reconstruction surgeries is mandated by law. This has made breast reconstruction more accessible to women who may not have been able to afford the procedure otherwise.

Which Factors Could Possibly Restrain the Growth of Mastectomy Reconstruction Implants Market?

Breast implants are not lifelong, and breast implant surgery carries the risk of complications that may eventually lead to the removal of the breast implants. Commonly observed complications include narrowing of the area around the implant (capsular contracture), additional surgery, and removal of the implant.

• According to a study published in the Annals of Surgery, the overall complication rate for breast reconstruction surgery was 23.5%, with infections and implant-related complications being the most common.

The increased risk of serious complications is a significant restraint to the growth of the breast reconstruction surgery and treatment market. Complications such as infection, bleeding, implant rupture or leaks, capsular contracture, and implant malposition can lead to additional surgeries, longer recovery times, and even permanent damage.

• Recent statistics from the American Society of Plastic Surgeons (ASPS) show that the overall complication rate for breast reconstruction surgery is 10%, with infections being the most common complication.

In addition to the risk of complications, the cost of breast reconstruction can also be a barrier in the market. The increased risk of serious complications is a significant barrier to the growth of the market. Women considering breast reconstruction surgery should carefully consider the potential risks and benefits and seek advice from a qualified healthcare provider. While mastectomy reconstruction implants are a popular option for breast reconstruction, some patients may opt for other treatments, such as autologous tissue reconstruction, which involves using tissue from the patient's own body to reconstruct the breast.

These factors are expected to hamper the revenue growth of the market over the forecast period.

Country-wise Insights

What Makes the USA the Dominating Country in the Mastectomy Reconstruction Implants Market?

The USA. dominated the global market in 2022 with a 94.5% value share in the North American market.

Favorable reimbursement policies are one of the key factors that make the USA the dominating country in the market. The Centers for Medicare & Medicaid Services (CMS) in the USA has established reimbursement policies that make breast reconstruction surgery and the use of mastectomy reconstruction implants more accessible and affordable for patients. Medicare, the federal health insurance program for people over 65 and those with certain disabilities covers breast reconstruction surgery and the use of mastectomy reconstruction implants following a mastectomy for breast cancer. Private insurance plans are also required to provide coverage for breast reconstruction surgery under the Women's Health and Cancer Rights Act of 1998.

• According to a study published in the journal Plastic and Reconstructive Surgery in 2018, the average Medicare reimbursement for breast reconstruction surgery and the use of implants was USD 9,593. The study also found that the reimbursement rate varied depending on the type of implant used, with silicone implants receiving higher reimbursement rates than saline implants.

Favorable reimbursement policies help to ensure that patients have access to mastectomy reconstruction implants and that healthcare providers can provide these services without financial barriers. This has helped to increase the adoption rate of breast reconstruction surgery and the use of mastectomy reconstruction implants in the USA

Why is Germany considered to be a Lucrative Segment for Mastectomy Reconstruction Implants Market in Western Europe?

Germany dominated the Western European market for mastectomy reconstruction implants and accounted for around 26.7% of the market share in 2022.

Breast reconstruction surgery has become more common in Germany due to increased awareness and education about the procedure, as well as advancements in surgical techniques and technology.

• According to a study published in the journal Geburtshilfe und Frauenheilkunde, the number of breast reconstruction surgeries performed in Germany increased by 40% between 2012 and 2018.

Germany also has a strong healthcare system with highly trained medical professionals, making it an attractive destination for medical tourism. Many women from other countries travel to Germany for breast reconstruction surgery, further driving demand for mastectomy reconstruction implants in the country.

What Makes Brazil an Emerging Market for Mastectomy Reconstruction Implant?

Brazil held nearly 49.5% of the Latin America market for mastectomy reconstruction implants.

The market in Brazil is expected to grow significantly in the coming years due to several factors. Brazil has a large population of over 211 million people, and breast cancer is the leading cancer among women in the country.

• According to the National Cancer Institute (INCA), breast cancer is the second most common cancer in Brazil, accounting for about 29% of all new cancer cases in women. The incidence of breast cancer in Brazil has been increasing in recent years, with an estimated 66,280 new cases expected in 2022. This high incidence of breast cancer creates a significant demand for breast reconstruction procedures and mastectomy reconstruction implants.
• Breast reconstruction surgery is becoming increasingly common in Brazil, with an estimated 15,000 breast reconstruction procedures performed in the country in 2020. This number is expected to increase as more women become aware of the benefits of breast reconstruction surgery and as healthcare providers become more skilled in performing the procedure.
• Overall, the large population and high incidence of breast cancer in Brazil make it a promising market for mastectomy reconstruction implants.

Category-wise Insights

Why Product Is Largely Adopted Treatment Option for Mastectomy Reconstruction Implant?

The direct-to-implant reconstruction segment held the major chunk of about 55.0% of the global market in 2022.

The implant is placed immediately after the mastectomy, the overall breast shape can be more easily controlled and optimized. Direct-to-Implant (DTI) reconstruction allows for the immediate placement of the implant, which means the overall breast shape can be more easily controlled and optimized. The surgeon can better adjust the size, shape, and position of the implant during surgery, resulting in a more natural-looking breast. Patients can see the results immediately after surgery, which can help alleviate anxiety and improve their overall satisfaction with the procedure.

Which End User Dominates the Global Market in 2022?

The hospitals segment accounted for a revenue share of 42.2% in the global market in 2022.

Mastectomy reconstruction implant surgery is a complex procedure that requires specialized equipment, facilities, and skilled healthcare professionals. Hospitals are well-equipped to handle such surgeries and have dedicated units and teams that specialize in breast reconstruction procedures. Hospitals are the preferred choice for patients undergoing breast reconstruction surgery due to the perceived safety and quality of care provided. Patients often prefer to undergo surgery in a hospital setting where they can receive specialized care and access to advanced medical technology.

Competitive Landscape

Key players in the market are focused on increase their product portfolio to strengthen their position in the market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and approvals of the products to expand their business.

For instance:

• In 2020, GC Aesthetics plc received approval from the FDA for its NaturaCel breast implants. These implants are designed to provide a natural look and feel for women undergoing breast reconstruction surgery.
• In 2020, Allergan, Inc. received approval for Natrelle Inspira SoftTouch breast implants from the USA Food and Drug Administration (FDA). These implants are designed to provide a softer feel and a more natural look for women who are undergoing breast reconstruction surgery.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the mastectomy reconstruction implants market space, which are available in the full report

Scope of the Mastectomy Reconstruction Implant Report

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2016 to 2022
Market Analysis	USD Million for Value
Key Regions Covered	North America; Latin America; East Asia; South Asia & Pacific; Western Europe; Eastern Europe; Central Asia; Russia & Belarus; Balkan & Baltic Countries; Middle East and Africa (MEA)
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, China, Japan, South Korea, India, Indonesia, Thailand, Philippines, Malaysia, Vietnam, Australia & New Zealand, Germany, France, Spain Italy, BENELUX, Nordic Countries, UK, Poland, Hungary, Romania, Czech Republic, Central Asia, Russia & Belarus, Balkan & Baltic Countries, GCC Countries, Kingdom of Saudi Arabia, Türkiye, Northern Africa, South Africa, Israel
Key Segments Covered	Product, End User, and Region
Key Companies Profiled	Mentor Worldwide LLC (Johnson & Johnson Services, Inc.); AbbVie Inc. (Allergan PLC); Hans Biomed Co., Ltd; Galderma SA; GC Aesthetics; POLYTECH Health & Aesthetics GmbH; Sintera Inc; PMT Corporation; Ideal Implant Inc; Groupe Sebbin SAS; Hologic, Inc; Guangzhou Wanhe Plastic Materials Co., Ltd; Establishment Labs S.A; RTI Surgical Holdings Inc.; Nagor Limited
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Key Segments Covered in Mastectomy Reconstruction Implant Industry Research

By Product:

• Two-Stage Implant Reconstruction (matrix (ADM))
  • Prepectoral Breast Reconstruction Surgery
  • Sub-pectoral Breast Reconstruction Surgery
• Direct-to-Implant Reconstruction

By End User:

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers
• Medical Spas

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Western Europe
• Eastern Europe
• Central Asia
• Russia & Belarus
• Balkan & Baltic Countries
• Middle East and Africa (MEA)

Frequently Asked Questions

What is the Estimated Size of the Mastectomy Reconstruction Implants Market in 2023?

The global market value could be around USD 2.09 billion in 2023.

Which Product Type is Growing at a Faster Rate in the Market?

Direct-to-implant reconstruction segment is expected to lead through 2033.

Which is the Leading Region for Mastectomy Reconstruction Implants Market?

The United States leads the market with a 94.5% share in 2022.

What is the Overall share of the Market from Hospital Segment?

The hospital segment captured an overall market share of 42.2% in the year 2022.

Which Country Dominates the Latin America Mastectomy Reconstruction Implants Market?

Brazil dominate the market, with a market share of around 49.5%.